Amphastar Pharmaceuticals AMPH Treasury Stock, Value
Treasury Stock, Value at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockValue.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's treasury stock, value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's treasury stock, value?
- Amphastar Pharmaceuticals (AMPH) reported treasury stock, value of $438M in Q1 2026.
- How has Amphastar Pharmaceuticals's treasury stock, value changed year-over-year?
- Amphastar Pharmaceuticals's treasury stock, value increased by 27.3% year-over-year, from $343.93M to $438M.
- What is the long-term trend for Amphastar Pharmaceuticals's treasury stock, value?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's treasury stock, value has grown at a 27.4% compound annual growth rate (CAGR), from $121.81M to $408.15M.
- What does treasury stock, value mean?
- This represents the cost of common shares that the company has repurchased from the open market and holds in its treasury. Treasury stock reduces total shareholders' equity and is often used for employee stock compensation plans or to return capital to shareholders. It is recorded as a contra-equity account.